肺纤维化疾病气道定量CT成像生物标志物2023 (AIIB23)

数据集说明

肺纤维化疾病气道定量CT成像生物标志物2023 (AIIB23) 对应论文数据集（arXiv 预印本）。

数据获取指引

1. 打开论文页面获取作者与项目信息：https://arxiv.org/abs/2312.13752v2
2. 论文 Data Availability / Code Availability 章节标注了数据实际托管位置；
3. 获取到实际数据链接后，按对应平台标准方式下载。

论文摘要：Abstract:Airway-related quantitative imaging biomarkers are crucial for examination, diagnosis, and prognosis in pulmonary diseases. However, the manual delineation of airway trees remains prohibitively time-consuming. While significant efforts have been made towards enhancing airway modelling, current public-available datasets concentrate on lung diseases with moderate morphological variations. The intricate honeycombing patterns present in the lung tissues of fibrotic lung disease patients exacerbate the challenges, often leading to various prediction errors. To address this issue, the 'Airway-Informed Quantitative CT Imaging Biomarker for Fibrotic Lung Disease 2023' (AIIB23) competition was organized in conjunction with the official 2023 International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI). The airway structures were meticulously annotated by three experienced radiologists. Competitors were encouraged to develop automatic airway segmentation models with high robustness and generalization abilities, followed by exploring the most correlated QIB of mortality prediction. A training set of 120 high-resolution computerised tomography (HRCT) scans were publicly released with expert annotations and mortality status. The online validation set incorporated 52 HRCT scans from patients with fibrotic lung disease and the offline test set included 140 cases from fibrosis and COVID-19 patients. The results have shown that the capacity of extracting airway trees from patients with fibrotic lung disease could be enhanced by introducing

论文页面：https://arxiv.org/abs/2312.13752v2